OpenURL Connection Search

Select item for more details and to access through your institution.

Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.
Published in:
International Journal of Hematology, 2013, v. 98, n. 1, p. 66, doi. 10.1007/s12185-013-1367-z
By:
- Nakamura, Shingen;
- Miki, Hirokazu;
- Kido, Shinsuke;
- Nakano, Ayako;
- Hiasa, Masahiro;
- Oda, Asuka;
- Amou, Hiroe;
- Watanabe, Keiichiro;
- Harada, Takeshi;
- Fujii, Shiro;
- Takeuchi, Kyoko;
- Kagawa, Kumiko;
- Ozaki, Shuji;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma.
Published in:
International Journal of Hematology, 2013, v. 97, n. 6, p. 743, doi. 10.1007/s12185-013-1321-0
By:
- Harada, Takeshi;
- Ozaki, Shuji;
- Oda, Asuka;
- Fujii, Shiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Kagawa, Kumiko;
- Takeuchi, Kyoko;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
Published in:
2011
By:
- Cui, Qu;
- Shibata, Hironobu;
- Oda, Asuka;
- Amou, Hiroe;
- Nakano, Ayako;
- Yata, Kenichiro;
- Hiasa, Masahiro;
- Watanabe, Keiichiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Harada, Takeshi;
- Fujii, Shiro;
- Kagawa, Kumiko;
- Takeuchi, Kyoko;
- Ozaki, Shuji;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
journal article
Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.
Published in:
2011
By:
- Nakano, Ayako;
- Abe, Masahiro;
- Oda, Asuka;
- Amou, Hiroe;
- Hiasa, Masahiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Harada, Takeshi;
- Fujii, Shirou;
- Kagawa, Kumiko;
- Takeuchi, Kyoko;
- Watanabe, Takashi;
- Ozaki, Shuji;
- Matsumoto, Toshio
Publication type:
journal article
Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.
Published in:
2009
By:
- Kitazoe, Ken-ichi;
- Abe, Masahiro;
- Hiasa, Masahiro;
- Oda, Asuka;
- Amou, Hiroe;
- Harada, Takeshi;
- Nakano, Ayako;
- Takeuchi, Kyoko;
- Hashimoto, Toshihiro;
- Ozaki, Shuji;
- Matsumoto, Toshio
Publication type:
journal article
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA.
Published in:
British Journal of Haematology, 2019, v. 185, n. 5, p. 969, doi. 10.1111/bjh.15673
By:
- Bat‐Erdene, Ariunzaya;
- Nakamura, Shingen;
- Oda, Asuka;
- Iwasa, Masami;
- Teramachi, Jumpei;
- Ashtar, Mohannad;
- Harada, Takeshi;
- Miki, Hirokazu;
- Tenshin, Hirofumi;
- Hiasa, Masahiro;
- Fujii, Shiro;
- Sogabe, Kimiko;
- Oura, Masahiro;
- Udaka, Kengo;
- Kagawa, Kumiko;
- Yoshida, Sumiko;
- Aihara, Ken‐ichi;
- Kurahashi, Kiyoe;
- Endo, Itsuro;
- Abe, Masahiro
Publication type:
Article
Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
Published in:
British Journal of Haematology, 2018, v. 180, n. 4, p. 581, doi. 10.1111/bjh.14388
By:
- Teramachi, Jumpei;
- Hiasa, Masahiro;
- Oda, Asuka;
- Harada, Takeshi;
- Nakamura, Shingen;
- Amachi, Ryota;
- Tenshin, Hirofumi;
- Iwasa, Masami;
- Fujii, Shiro;
- Kagawa, Kumiko;
- Miki, Hirokazu;
- Kurahashi, Kiyoe;
- Yoshida, Sumiko;
- Endo, Itsuro;
- Haneji, Tatsuji;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity.
Published in:
British Journal of Haematology, 2018, v. 180, n. 2, p. 246, doi. 10.1111/bjh.15033
By:
- Fujii, Shiro;
- Nakamura, Shingen;
- Oda, Asuka;
- Miki, Hirokazu;
- Tenshin, Hirofumi;
- Teramachi, Jumpei;
- Hiasa, Masahiro;
- Bat‐Erdene, Ariunzaya;
- Maeda, Yusaku;
- Oura, Masahiro;
- Takahashi, Mamiko;
- Iwasa, Masami;
- Endo, Itsuro;
- Yoshida, Sumiko;
- Aihara, Ken‐ichi;
- Kurahashi, Kiyoe;
- Harada, Takeshi;
- Kagawa, Kumiko;
- Nakao, Michiyasu;
- Sano, Shigeki
Publication type:
Article
Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors.
Published in:
PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083905
By:
- Harada, Takeshi;
- Ozaki, Shuji;
- Oda, Asuka;
- Tsuji, Daisuke;
- Ikegame, Akishige;
- Iwasa, Masami;
- Udaka, Kengo;
- Fujii, Shiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Kagawa, Kumiko;
- Kuroda, Yoshiaki;
- Kawai, Shigeto;
- Itoh, Kohji;
- Yamada-Okabe, Hisafumi;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL.
Published in:
PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031594
By:
- Kagawa, Kumiko;
- Nakano, Ayako;
- Miki, Hirokazu;
- Oda, Asuka;
- Amou, Hiroe;
- Takeuchi, Kyoko;
- Nakamura, Shingen;
- Harada, Takeshi;
- Fujii, Shiro;
- Yata, Kenichiro;
- Ozaki, Shuji;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells.
Published in:
PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027222
By:
- Nakano, Ayako;
- Tsuji, Daisuke;
- Miki, Hirokazu;
- Qu Cui;
- Sayed, Salah Mohamed El;
- Ikegame, Akishige;
- Oda, Asuka;
- Amou, Hiroe;
- Nakamura, Shingen;
- Harada, Takeshi;
- Fujii, Shiro;
- Kagawa, Kumiko;
- Takeuchi, Kyoko;
- Sakai, Akira;
- Ozaki, Shuji;
- Okano, Kazuma;
- Nakamura, Takahiro;
- Itoh, Kohji;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth.
Published in:
PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009870
By:
- Takeuchi, Kyoko;
- Abe, Masahiro;
- Hiasa, Masahiro;
- Oda, Asuka;
- Amou, Hiroe;
- Kido, Shinsuke;
- Harada, Takeshi;
- Tanaka, Osamu;
- Miki, Hirokazu;
- Nakamura, Shingen;
- Nakano, Ayako;
- Kagawa, Kumiko;
- Yata, Kenichiro;
- Ozaki, Shuji;
- Matsumoto, Toshio
Publication type:
Article
The Numerical Analysis and Experiment of Shock Processing for Bouef.
Published in:
International Journal of Multiphysics, 2010, v. 4, n. 4, p. 329, doi. 10.1260/1750-9548.4.4.329
By:
- Yamashita, Yusuke;
- Oda, Asuka;
- Hujii, Takeshi;
- Maehara, Hironori;
- Moatamedi, M;
- Itoh, Shigeru
Publication type:
Article
The Numerical Analysis and Experiment of Shock Processing for Bouef.
Published in:
International Journal of Multiphysics, 2010, v. 4, n. 4, p. 329, doi. 10.1260/1750-9548.4.4.329
By:
- YAMASHITA, Yusuke;
- ODA, Asuka;
- HUJII, Takeshi;
- MAEHARA, Hironori;
- Moatamedi, M.;
- ITOH, Shigeru
Publication type:
Article
The numerical analysis of food processing using shock wave.
Published in:
International Journal of Multiphysics, 2009, v. 3, n. 4, p. 337, doi. 10.1260/1750-9548.3.4.337
By:
- Yamashita, Yusuke;
- Oda, Asuka;
- Maehara, Hironori;
- Watanabe, Toshiaki;
- Motamedi, M.;
- Itoh, Shigeru
Publication type:
Article
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
Published in:
Cancers, 2020, v. 12, n. 4, p. 929, doi. 10.3390/cancers12040929
By:
- Ashtar, Mohannad;
- Tenshin, Hirofumi;
- Teramachi, Jumpei;
- Bat-Erdene, Ariunzaya;
- Hiasa, Masahiro;
- Oda, Asuka;
- Tanimoto, Kotaro;
- Shimizu, So;
- Higa, Yoshiki;
- Harada, Takeshi;
- Oura, Masahiro;
- Sogabe, Kimiko;
- Nakamura, Shingen;
- Fujii, Shiro;
- Sumitani, Ryohei;
- Miki, Hirokazu;
- Udaka, Kengo;
- Takahashi, Mamiko;
- Kagawa, Kumiko;
- Endo, Itsuro
Publication type:
Article
P-005: Novel strategy of elotuzumab and zoledronic acid with Th1-like γδT cells against myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S41, doi. 10.1016/S2152-2650(21)02139-X
By:
- Takeshi Harada;
- Yusuke Inoue;
- Hirofumi Tenshin;
- Asuka Oda;
- Ryohei Sumitani;
- Masahiro Oura;
- Kimiko Sogabe;
- Shiro Fujii;
- Shingen Nakamura;
- Hirokazu Miki;
- Masahiro Hiasa;
- Jumpei Teramachi;
- Masahiro Abe
Publication type:
Article
Synergistic targeting of Sp1 in myeloma cells with hyperthermia plus proteasome inhibitors.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e132, doi. 10.1016/j.clml.2019.09.219
By:
- Miki, Hirokazu;
- Nakamura, Shingen;
- Bat-Erdene, Ariunzaya;
- Tenshin, Hirofumi;
- Teramachi, Jumpei;
- Oda, Asuka;
- Kawata, Shiyori;
- Hori, Taiki;
- Murai, Jumpei;
- Sumitani, Ryohei;
- Oura, Masahiro;
- Sogabe, Kimiko;
- Takahashi, Mamiko;
- Udaka, Kengo;
- Harada, Takeshi;
- Fujii, Shiro;
- Kagawa, Kumiko;
- Abe, Masahiro
Publication type:
Article
A progressive auto-amplification loop in TAK1 expression and activation in myeloma cells.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e111, doi. 10.1016/j.clml.2019.09.183
By:
- Teramachi, Jumpei;
- Shimizu, So;
- Harada, Takeshi;
- Tenshin, Hirofumi;
- Oda, Asuka;
- Bat-Erdene, Ariunzaya;
- Hiasa, Masahiro;
- Tanimoto, Kotaro;
- Endo, Itsuro;
- Matsumoto, Toshio;
- Tanaka, Eiji;
- Abe, Masahiro
Publication type:
Article
Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e105, doi. 10.1016/j.clml.2019.09.173
By:
- Harada, Takeshi;
- Oda, Asuka;
- Tenshin, Hirofumi;
- Teramachi, Jumpei;
- Oura, Masahiro;
- Sogabe, Kimiko;
- Fujii, Shiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Kagawa, Kumiko;
- Ozaki, Shuji;
- Hideshima, Teru;
- Anderson, Kenneth C.;
- Abe, Masahiro
Publication type:
Article
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
Published in:
Antioxidants, 2023, v. 12, n. 1, p. 133, doi. 10.3390/antiox12010133
By:
- Higa, Yoshiki;
- Hiasa, Masahiro;
- Tenshin, Hirofumi;
- Nakaue, Emiko;
- Tanaka, Mariko;
- Kim, Sooha;
- Nakagawa, Motosumi;
- Shimizu, So;
- Tanimoto, Kotaro;
- Teramachi, Jumpei;
- Harada, Takeshi;
- Oda, Asuka;
- Oura, Masahiro;
- Sogabe, Kimiko;
- Hara, Tomoyo;
- Sumitani, Ryohei;
- Maruhashi, Tomoko;
- Yamagami, Hiroki;
- Endo, Itsuro;
- Matsumoto, Toshio
Publication type:
Article
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
Published in:
International Journal of Hematology, 2024, v. 119, n. 6, p. 626, doi. 10.1007/s12185-024-03763-7
By:
- Inoue, Yusuke;
- Oda, Asuka;
- Maeda, Yusaku;
- Sumitani, Ryohei;
- Oura, Masahiro;
- Sogabe, Kimiko;
- Maruhashi, Tomoko;
- Takahashi, Mamiko;
- Fujii, Shiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Hiasa, Masahiro;
- Teramachi, Jumpei;
- Harada, Takeshi;
- Abe, Masahiro
Publication type:
Article
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
Published in:
International Journal of Hematology, 2024, v. 119, n. 3, p. 291, doi. 10.1007/s12185-023-03706-8
By:
- Maruhashi, Tomoko;
- Miki, Hirokazu;
- Sogabe, Kimiko;
- Oda, Asuka;
- Sumitani, Ryohei;
- Oura, Masahiro;
- Takahashi, Mamiko;
- Harada, Takeshi;
- Fujii, Shiro;
- Nakamura, Shingen;
- Kurahashi, Kiyoe;
- Endo, Itsuro;
- Abe, Masahiro
Publication type:
Article
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Published in:
International Journal of Hematology, 2024, v. 119, n. 3, p. 303, doi. 10.1007/s12185-023-03705-9
By:
- Sogabe, Kimiko;
- Nakamura, Shingen;
- Higa, Yoshiki;
- Miki, Hirokazu;
- Oda, Asuka;
- Maruhashi, Tomoko;
- Sumitani, Ryohei;
- Oura, Masahiro;
- Takahashi, Mamiko;
- Nakamura, Masafumi;
- Maeda, Yusaku;
- Hara, Tomoyo;
- Yamagami, Hiroki;
- Fujii, Shiro;
- Kagawa, Kumiko;
- Ozaki, Shuji;
- Kurahashi, Kiyoe;
- Endo, Itsuro;
- Aihara, Ken-ichi;
- Nakaue, Emiko
Publication type:
Article
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
Published in:
International Journal of Hematology, 2023, v. 118, n. 1, p. 88, doi. 10.1007/s12185-023-03601-2
By:
- Nakaue, Emiko;
- Teramachi, Jumpei;
- Tenshin, Hirofumi;
- Hiasa, Masahiro;
- Harada, Takeshi;
- Oda, Asuka;
- Inoue, Yusuke;
- Shimizu, So;
- Higa, Yoshiki;
- Sogabe, Kimiko;
- Oura, Masahiro;
- Hara, Tomoyo;
- Sumitani, Ryohei;
- Maruhashi, Tomoko;
- Yamagami, Hiroki;
- Endo, Itsuro;
- Tanaka, Eiji;
- Abe, Masahiro
Publication type:
Article
TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression.
Published in:
Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1371
By:
- Tenshin, Hirofumi;
- Teramachi, Jumpei;
- Ashtar, Mohannad;
- Hiasa, Masahiro;
- Inoue, Yusuke;
- Oda, Asuka;
- Tanimoto, Kotaro;
- Shimizu, So;
- Higa, Yoshiki;
- Harada, Takeshi;
- Oura, Masahiro;
- Sogabe, Kimiko;
- Hara, Tomoyo;
- Sumitani, Ryohei;
- Maruhashi, Tomoko;
- Sebe, Mayu;
- Tsutsumi, Rie;
- Sakaue, Hiroshi;
- Endo, Itsuro;
- Matsumoto, Toshio
Publication type:
Article
Phase appearance during polymerization of fluorinated polyimide monomers and deposition into the microscopic-scale trenches in supercritical carbon dioxide.
Published in:
Journal of Applied Polymer Science, 2016, v. 133, n. 20, p. n/a, doi. 10.1002/app.43334
By:
- Haruki, Masashi;
- Oda, Asuka;
- Wasada, Atsuhiko;
- Hasegawa, Yumi;
- Kihara, Shin-ichi;
- Takishima, Shigeki
Publication type:
Article
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.
Published in:
British Journal of Haematology, 2011, v. 155, n. 3, p. 328, doi. 10.1111/j.1365-2141.2011.08844.x
By:
- Miki, Hirokazu;
- Ozaki, Shuji;
- Nakamura, Shingen;
- Oda, Asuka;
- Amou, Hiroe;
- Ikegame, Akishige;
- Watanabe, Keiichiro;
- Hiasa, Masahiro;
- Cui, Qu;
- Harada, Takeshi;
- Fujii, Shiro;
- Nakano, Ayako;
- Kagawa, Kumiko;
- Takeuchi, Kyoko;
- Yata, Ken-ichiro;
- Sakai, Akira;
- Abe, Masahiro;
- Matsumoto, Toshio
Publication type:
Article
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.
Published in:
Journal of Bioenergetics & Biomembranes, 2012, v. 44, n. 1, p. 31, doi. 10.1007/s10863-012-9412-9
By:
- Nakano, Ayako;
- Miki, Hirokazu;
- Nakamura, Shingen;
- Harada, Takeshi;
- Oda, Asuka;
- Amou, Hiroe;
- Fujii, Shiro;
- Kagawa, Kumiko;
- Takeuchi, Kyoko;
- Ozaki, Shuji;
- Matsumoto, Toshio;
- Abe, Masahiro
Publication type:
Article
Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma.
Published in:
EJHaem, 2023, v. 4, n. 3, p. 667, doi. 10.1002/jha2.758
By:
- Oura, Masahiro;
- Harada, Takeshi;
- Oda, Asuka;
- Teramachi, Jumpei;
- Nakayama, Atsushi;
- Sumitani, Ryohei;
- Inoue, Yusuke;
- Maeda, Yusaku;
- Sogabe, Kimiko;
- Maruhashi, Tomoko;
- Takahashi, Mamiko;
- Fujii, Shiro;
- Nakamura, Shingen;
- Miki, Hirokazu;
- Nakamura, Masafumi;
- Hara, Tomoyo;
- Yamagami, Hiroki;
- Kurahashi, Kiyoe;
- Endo, Itsuro;
- Hasegawa, Hiroo
Publication type:
Article
Factors contributing to deep supercooling capability and cold survival in dwarf bamboo (Sasa senanensis) leaf blades.
Published in:
Frontiers in Plant Science, 2015, v. 5, p. 1, doi. 10.3389/fpls.2014.00791
By:
- Masaya Ishikawa;
- Asuka Oda;
- Reiko Fukami;
- Akira Kuriyama
Publication type:
Article

Found: 31